Action for Health in Diabetes Study
About the dataset
Primary description: Diabetes weight loss trial
| Study | Action for Health in Diabetes Study (Look AHEAD) | |
|---|---|---|
| Study Website | lookAHEAD | |
| Data Descriptor Paper | https://doi.org/10.1093/gerona/glz090 | |
| DUA | https://repository.niddk.nih.gov/pages/for_requestors | |
| Country/Region | USA | |
| Disease Tag | cardiovascular | |
| Age (mean ± SD) | 68.4 ± 6.5 | |
| Age Range | 54.10-84.08 | |
| % Female | 71.1 | |
| CUBIC Project | /cbica/projects/LookAhead |
|
| PI for CUBIC Access Approval | Christos Davatzikos | |
| N Subjects | 311 | |
| N MR Sessions | 311 | |
|
DLMUSE
(v1.0.7)
(319/319 complete) |
/cbica/projects/LookAhead/Pipelines/LookAhead_DLMUSE_2025/Results/DLMUSE_Volumes.csv
|
|
|
RAVENS
(DRAMMS-1.4.1)
(316/316 complete) |
/cbica/projects/LookAhead/Pipelines/LookAhead_3D_2021/Protocols/RAVENS
|
|
|
DLWMLS
(v0.1.0)
(316/316 complete) |
/cbica/projects/LookAhead/Pipelines/LookAhead_DLWMLS_2025/Results/LookAhead_DLWMLS_DLMUSE_Segmented_Volumes.csv
|
|
| Non-Imaging Data |
/cbica/projects/ISTAGING/Pipelines/ClinicalDataConsolidation_201911/Data/External_Data/lookAHEAD
Raw data downloaded from source. /cbica/projects/ISTAGING/Pipelines/ClinicalDataConsolidation_201911/dictionaries/LookAhead
Data dictionary of raw data downloaded from source. /cbica/projects/ISTAGING/Pipelines/ISTAGING_Data_Consolidation_2020/v2.0/istaging.csv
Data consolidated and harmonized in 2020. This study: subset with README: Release Notes: /cbica/home/harmang/for_others/final_combined_istaging_withMUSE.csv
Data consolidated and harmonized in 2026. This study: subset with |
Funding
The Look AHEAD Brain MRI ancillary study was supported by the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Department of Health and Human Services: DK092237-01. Additional support was provided bythe Action for Health in Diabetes ADRD Study (Look AHEAD-MIND) R01AG058571.
The Action for Health in Diabetes is supported through the following cooperative agreements from the National Institutes of Health: DK57136, DK57149, DK56990, DK57177, DK57171, DK57151, DK57182, DK57131, DK57002, DK57078, DK57154, DK57178, DK57219, DK57008, DK57135, and DK56992. The following federal agencies have contributed support: National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; National Institute of Nursing Research; National Center on Minority Health and Health Disparities; Office of Research on Women’s Health; the Centers for Disease Control and Prevention; and the Department of Veterans Affairs. This research was supported in part by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases. The Indian Health Service (I.H.S.) provided personnel, medical oversight, and use of facilities. The opinions expressed in this paper are those of the authors and do not necessarily reflect the views of the I.H.S. or other funding sources.
Additional support was received from the University of Pittsburgh General Clinical Research Center (GCRC) (M01RR000056), the Clinical Translational Research Center (CTRC) funded by the Clinical & Translational Science Award (UL1 RR 024153) and NIH grant (DK 046204); Frederic C. Bartter General Clinical Research Center (M01RR01346); and the Wake Forest Alzheimer’s Disease Research Center (P30AG049638-01A1). JAL was also additionally supported by K24AG045334. HNY was supported by the NIH grants R21AG056518, R01AG055770 and R01AG054434.
The following organizations have committed to make major contributions to Look AHEAD: FedEx Corporation; Health Management Resources; LifeScan, Inc., a Johnson & Johnson Company; OPTIFAST® of Nestle HealthCare Nutrition, Inc.; Hoffmann-La Roche Inc.; Abbott Nutrition; and Slim-Fast Brand of Unilever North America.